Economic burden of cancer across the European Union: a population-based cost analysis
Top Cited Papers
- 1 November 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 14 (12), 1165-1174
- https://doi.org/10.1016/s1470-2045(13)70442-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Technology Assessment for New Oncology DrugsClinical Cancer Research, 2013
- An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case Of CancerHealth Affairs, 2012
- Delivering affordable cancer care in high-income countriesThe Lancet Oncology, 2011
- Progress against cancer (1971–2011): how far have we come?Journal of Internal Medicine, 2011
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous SystemJNCI Journal of the National Cancer Institute, 2011
- Economic burden of cardiovascular diseases in the enlarged European UnionEuropean Heart Journal, 2006
- The Relation between Funding by the National Institutes of Health and the Burden of DiseaseThe New England Journal of Medicine, 1999
- The friction cost method: A commentJournal of Health Economics, 1997
- Towards a new approach for estimating indirect costs of diseaseSocial Science & Medicine (1982), 1992
- Annual Costs of Illness versus Lifetime Costs of Illness and Implications of Structural ChangeDrug Information Journal, 1988